文献速递瘢痕与激光

病灶内维拉帕米与糖皮质激素治疗瘢痕疙瘩和增生性瘢痕的随机对照试验比较

Comparison of intralesional verapamil versus intralesional corticosteroids in treatment of keloids and hypertrophic scars: A randomized controlled trial.
PubMed 文献 · Burns · 2018-06-07

这项随机对照试验采用配对设计纳入50例有2个及以上瘢痕疙瘩的患者,对照侧病灶注射曲安奈德(40mg/mL),另一侧注射维拉帕米(2.5mg/mL),均每三周一次共18周,随访3个月。结果显示仅曲安奈德组在瘢痕高度和柔软度方面达到VSS零分,维拉帕米组无治疗事件或显著改善,不支持维拉帕米治疗瘢痕疙瘩或增生性瘢痕。

要点

  • 曲安奈德组在瘢痕高度和柔软度上达到VSS零分。
  • 维拉帕米组未见治疗事件或显著改善。
  • 结果不支持维拉帕米用于瘢痕疙瘩或增生性瘢痕。

核心结论

  • 结果不支持维拉帕米治疗瘢痕疙瘩或增生性瘢痕的能力。

研究设计与样本

  • 随机对照试验,采用配对设计,纳入50例有2个及以上瘢痕疙瘩的患者。
  • 对照侧50个病灶注射曲安奈德40mg/mL,另一侧50个病灶注射维拉帕米2.5mg/mL,均每三周一次共18周。

主要发现

  • 仅曲安奈德组在瘢痕高度(第15周)和柔软度(第15周)方面达到VSS零分。
  • 维拉帕米组无治疗事件(参数=0)或显著改善。
  • 各阶段及3个月随访结束时通过系列照片记录和VSS评估瘢痕。

临床怎么用

  • 临床治疗瘢痕疙瘩和增生性瘢痕时,不应期待维拉帕米达到与曲安奈德相当的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Keloids and hypertrophic scars are due to overgrowth of dermal collagen following trauma to the skin that usually cause major physical, psychological and cosmetic problems. METHODS: In this randomized controlled trial, with a paired design, 50 patients with 2 or more keloids were included. In the control group (50 lesions), intralesional triamcinolone acetonide (40mg/mL) was injected at three-week intervals for a total of 18weeks. In the other group (50 lesions), lesions were treated by verapamil (2.5mg/mL) with the same therapeutic sessions. Scar evaluation at each stage and at the end of 3months follow up was done by serial photographic records as well as by Vancouver Scar Scale (VSS). RESULTS: Mean zero VSS scores were achieved with only triamcinolone in respect of scar height (week 15th) and pliability (week 15th). No therapeutic event (parameter=0) or significant improvement was seen in verapamil group. CONCLUSION: Our results did not support verapamil's capability in treatment of keloid nor hypertrophic scars.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Abedini R, Sasani P, Mahmoudi HR, et al. Comparison of intralesional verapamil versus intralesional corticosteroids in treatment of keloids and hypertrophic scars: A randomized controlled trial. Burns. 2018. PMID: 29886113. doi:10.1016/j.burns.2018.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。